NCT00312026View on ClinicalTrials.gov

A Study to Evaluate the Safety and Efficacy of Efalizumab in Adult Patients With Plaque Psoriasis Involving the Hands and/or Feet

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

March 30, 2006

Primary Completion Date

November 28, 2006

Study Completion Date

November 28, 2006

Conditions
Psoriasis
Interventions
DRUG

efalizumab

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY